Disease: Atherosclerosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.050 Biomarker disease BEFREE TWEAK, when binding to its initial receptor, fibroblast growth factor inducible molecule 14 (Fn14), exerts adverse biological functions in atherosclerosis, including dysfunction of endothelial cells, phenotypic change of smooth muscle cells and inflammatory responses of monocytes/macrophages. 28781615 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.050 Biomarker disease BEFREE TWEAK-Fn14 may be a therapeutic target in the prothrombotic complications associated with atherosclerosis. 20810696 2011
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.050 Biomarker disease BEFREE TWEAK and Fn14. New players in the pathogenesis of atherosclerosis. 17485328 2007
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.050 Biomarker disease BEFREE Recent studies have revealed that the TWEAK-Fn14 ligand-receptor pair likely plays an important role in a variety of cellular processes and in the pathogenesis of several human diseases, including atherosclerosis, stroke, rheumatoid arthritis and cancer. 17127278 2007
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.050 AlteredExpression disease LHGDN TWEAK and Fn14 are expressed in atherosclerotic plaques and could be novel mediators of atherosclerosis. 16809572 2006